RxDoctor Payments Data

Sara Marcino

Psychiatry · Charleston, SCNPI 1609829886

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,877 of the $11,333 with a category attached, or 87.2%. 27 manufacturers reported payments, led by AbbVie at 25.2% of the total. 2025 is the largest year on record at $3,565, 5.6 times the $638 reported in 2019. Among psychiatry clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,333in general payments, 2019–2025

Across 549 payments — averaging $20.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Otsuka America Pharmaceutical, Inc.$996
  • Ironshore Pharmaceuticals Inc.$760
  • Axsome Therapeutics, Inc.$736
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$663
  • Sunovion Pharmaceuticals Inc.$590
  • plus $5K from 21 others

What the payments were for

  • Consulting fees$1,35012%
  • Food & beverage$9,87787%
  • Education$1061%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,333 in reported general payments places this provider in the 90th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lamotrigine72$1,635
Desvenlafaxine Succinate ErDesvenlafaxine Succinate19$1,592
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine75$1,588
Duloxetine Hcl81$1,491
Quetiapine Fumarate61$1,171
Pramipexole DihydrochloridePramipexole Di-Hcl36$926
Methylphenidate ErMethylphenidate Hcl17$826
Bupropion XlBupropion Hcl44$782
Escitalopram Oxalate42$776
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine19$612
Clonazepam58$551
Sertraline Hcl56$406
Gabapentin15$345
Fluoxetine Hcl27$292
Trazodone Hcl23$235

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Almatica Pharma LLCSertraline Hcl$363$40656 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →